Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JHS Svendgaard Laboratories's EBIT per Share for the
three
months ended in Mar. 2026 was ₹-0.33.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-0.18.
During the past 3 years, the average EBIT per Share Growth Rate was 33.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for JHS Svendgaard Laboratories's EBIT per Share or its related term are showing as below:
NSE:JHS'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -60.1 Med: -10.65 Max: 41.3
Current: 33
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of JHS Svendgaard Laboratories was 41.30% per year. The lowest was -60.10% per year. And the median was -10.65% per year.
NSE:JHS's 3-Year EBIT Growth Rate is ranked better than 79.05% of 1585
companies
in the Consumer Packaged Goods industry
Industry Median: 6.9
vs NSE:JHS: 33.00
JHS Svendgaard Laboratories (NSE:JHS) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
JHS Svendgaard Laboratories EBIT per Share Related Terms
JHS Svendgaard Laboratories EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-0.18
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JHS Svendgaard Laboratories (NSE:JHS) has a EBIT per Share of ₹-0.18 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on JHS Svendgaard Laboratories and its competitors. According to the industry distribution chart, JHS Svendgaard Laboratories ranks #332 out of 1585 companies in the Consumer Packaged Goods industry, placing it in the top 20.9%.
Is JHS Svendgaard Laboratories' EBIT per Share too high?
JHS Svendgaard Laboratories' current EBIT per Share is ₹-0.18. Based on the distribution chart, JHS Svendgaard Laboratories ranks #332 out of 1585 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, JHS Svendgaard Laboratories has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does JHS Svendgaard Laboratories' EBIT per Share compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, JHS Svendgaard Laboratories ranks #332 out of 1585 companies for EBIT per Share. This places JHS Svendgaard Laboratories in the top 21% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 6.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Consumer Packaged Goods company?
The median EBIT per Share among Consumer Packaged Goods companies is 6.90, based on 1,585 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on JHS Svendgaard Laboratories and its competitors. For the Consumer Packaged Goods industry, the median EBIT per Share is 6.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JHS Svendgaard Laboratories's current EBIT per Share is ₹-0.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JHS Svendgaard Laboratories stock overvalued right now?
Based on GuruFocus' analysis, JHS Svendgaard Laboratories (NSE:JHS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹21.78, compared to a current price of ₹7.39 — trading 66.1% below its estimated fair value. The current EBIT per Share is ₹-0.18. JHS Svendgaard Laboratories' overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For JHS Svendgaard Laboratories (NSE:JHS), the current EBIT per Share is ₹-0.18 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JHS Svendgaard Laboratories (NSE:JHS) Overvalued in 2026?
Based on GuruFocus' analysis, JHS Svendgaard Laboratories stock appears to be undervalued.
The current stock price of ₹7.39 is trading 66.1% below its estimated GF Value™ of ₹21.78.
GuruFocus considers JHS Svendgaard Laboratories to be Possible Value Trap.
Key valuation signals for NSE:JHS:
EBIT per Share: ₹-0.18
GF Value™: ₹21.78 vs. price of ₹7.39 (66.1% below fair value)
No single metric tells the full story. See the NSE:JHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JHS Svendgaard Laboratories Ltd is engaged in manufacturing a range of oral and dental products for elite national and international brands. The main portfolio of the Group is to carry out manufacturing and exporting of oral care and hygiene products, including toothbrushes, toothpastes, mouthwash, sanizers, and job work of detergent powder. The Company is into manufacturing toothpaste, toothbrushes, Talcum, and Others. The toothbrushes segment generates the key revenue.
50GF Score
Get the complete analysis for NSE:JHS
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:JHS has been successfully added to your 
